Fotemustine Compared With Dacarbazine in Patients With Disseminated Malignant Melanoma: A Phase III Study - Concepedia

Concepedia

Publication | Closed Access

Fotemustine Compared With Dacarbazine in Patients With Disseminated Malignant Melanoma: A Phase III Study

470

Citations

22

References

2004

Year

Marie‐Françoise Avril, Steinar Aamdal, Jean‐Jacques Grob, Axel Hauschild, Peter Mohr, J. J. Bonerandi, Michael Weichenthal, K. Neuber, Thomas Bieber, Katalin Gilde,

Journal of Clinical Oncology

Abstract

ORR was higher in the fotemustine arm compared to the DTIC arm in first-line treatment of disseminated melanoma. A trend in favor of fotemustine in terms of overall survival and time to BM was evidenced.

References

	Year	Citations

Page 1